Approximately 1% of non-MCC patients have low titer of antibodies against these oncoprotein probably because of low viral activity or latent infection and the fact that LT is a nuclear protein, reducing its processing and presentation by HLA class 1 [251]. The gene discussed is LTA; the disease is Merkel cell skin cancer.